Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.69 billion. The enterprise value is $2.27 billion.
| Market Cap | 1.69B |
| Enterprise Value | 2.27B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 51.21 million shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 51.21M |
| Shares Outstanding | 51.21M |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 10.71% |
| Owned by Institutions (%) | 64.31% |
| Float | 45.71M |
Valuation Ratios
The trailing PE ratio is 30.58 and the forward PE ratio is 18.69.
| PE Ratio | 30.58 |
| Forward PE | 18.69 |
| PS Ratio | 0.45 |
| Forward PS | 0.41 |
| PB Ratio | 1.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 17.77 |
| P/OCF Ratio | 15.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.19, with an EV/FCF ratio of 23.62.
| EV / Earnings | 44.19 |
| EV / Sales | 0.60 |
| EV / EBITDA | 14.19 |
| EV / EBIT | 22.94 |
| EV / FCF | 23.62 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 1.55.
| Current Ratio | 1.25 |
| Quick Ratio | 1.21 |
| Debt / Equity | 1.55 |
| Debt / EBITDA | 5.38 |
| Debt / FCF | 9.83 |
| Interest Coverage | 1.47 |
Financial Efficiency
Return on equity (ROE) is 9.85% and return on invested capital (ROIC) is 5.78%.
| Return on Equity (ROE) | 9.85% |
| Return on Assets (ROA) | 2.79% |
| Return on Invested Capital (ROIC) | 5.78% |
| Return on Capital Employed (ROCE) | 6.57% |
| Weighted Average Cost of Capital (WACC) | 8.84% |
| Revenue Per Employee | $1.30M |
| Profits Per Employee | $17,709 |
| Employee Count | 3,000 |
| Asset Turnover | 1.71 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $28.23 million in taxes.
| Income Tax | 28.23M |
| Effective Tax Rate | 32.58% |
Stock Price Statistics
The stock price has increased by +31.00% in the last 52 weeks. The beta is 1.24, so Astrana Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +31.00% |
| 50-Day Moving Average | 36.89 |
| 200-Day Moving Average | 34.13 |
| Relative Strength Index (RSI) | 36.82 |
| Average Volume (20 Days) | 329,568 |
Short Selling Information
The latest short interest is 3.01 million, so 5.88% of the outstanding shares have been sold short.
| Short Interest | 3.01M |
| Short Previous Month | 3.09M |
| Short % of Shares Out | 5.88% |
| Short % of Float | 6.59% |
| Short Ratio (days to cover) | 6.90 |
Income Statement
In the last 12 months, Astrana Health had revenue of $3.91 billion and earned $53.13 million in profits. Earnings per share was $1.08.
| Revenue | 3.91B |
| Gross Profit | 428.36M |
| Operating Income | 102.36M |
| Pretax Income | 86.65M |
| Net Income | 53.13M |
| EBITDA | 165.41M |
| EBIT | 102.36M |
| Earnings Per Share (EPS) | $1.08 |
Balance Sheet
The company has $396.23 million in cash and $977.38 million in debt, with a net cash position of -$581.16 million or -$11.35 per share.
| Cash & Cash Equivalents | 396.23M |
| Total Debt | 977.38M |
| Net Cash | -581.16M |
| Net Cash Per Share | -$11.35 |
| Equity (Book Value) | 631.50M |
| Book Value Per Share | 17.37 |
| Working Capital | 193.91M |
Cash Flow
In the last 12 months, operating cash flow was $114.19 million and capital expenditures -$14.78 million, giving a free cash flow of $99.42 million.
| Operating Cash Flow | 114.19M |
| Capital Expenditures | -14.78M |
| Depreciation & Amortization | 63.05M |
| Net Borrowing | -127.87M |
| Free Cash Flow | 99.42M |
| FCF Per Share | $1.94 |
Margins
Gross margin is 10.95%, with operating and profit margins of 2.62% and 1.36%.
| Gross Margin | 10.95% |
| Operating Margin | 2.62% |
| Pretax Margin | 2.22% |
| Profit Margin | 1.36% |
| EBITDA Margin | 4.23% |
| EBIT Margin | 2.62% |
| FCF Margin | 2.54% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.20% |
| Shareholder Yield | -1.20% |
| Earnings Yield | 3.27% |
| FCF Yield | 5.63% |
Analyst Forecast
The average price target for Astrana Health is $52.11, which is 57.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $52.11 |
| Price Target Difference | 57.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 14.70% |
| EPS Growth Forecast (3Y) | 28.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 2.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 7 |